Tspan15‐ADAM10 signalling enhances cancer stem cell‐like properties and induces chemoresistance via Notch1 activation in ICC
Liver International · 2023
DOI: 10.1111/liv.15691 ↗Kurz gefasst
Fachartikel in der Zeitschrift Liver International, 2023. Verfasst von Arihito Yoshizumi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, Graduate School of Medicine, Chiba University, Chiba, Japan. Hauptthemen laut MEDLINE: Drug Resistance, Neoplasm, Neoplasms. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 44 Literaturangaben. Gefördert von: Japan Society for the Promotion of Science.
Abstract (Originalsprache)
Background & Aims Notch1 activation promotes ICC progression and is associated with chemoresistance; however, therapies directly targeting Notch1 showed severe adverse effects. Notch1 activation is mediated by ADAM10, a molecular scissor that separates the target protein from its substrates in the cell membrane. Tspan15 regulates ADAM10 function, but the role of Tspan15 in ICC progression is unclear.
Methods
Tspan15, ADAM10, and Notch1 expression and activation in fresh surgical specimens from 80 ICC patients and ICC cells were evaluated by immunohistochemistry, RT‐PCR, western blotting, and flow cytometry.
Results
Tspan15 expression was increased in ICC compared with adjacent liver tissue, and high Tspan15 expression was an independent factor for poor prognosis. In ICC with high Tspan15 expression, vascular invasion, lymph node metastasis, and haematogenous recurrence were increased. Tspan15 was co‐expressed with ADAM10 in ICC, and associated with the expression of stemness and EMT markers. In ICC cells, Tspan15 induced ADAM10 activation by mediating the translocation of activated m‐ADAM10 from the cytoplasm to the surface of the cell membrane, which further activated Notch1 by separating the intracellular domain of Notch1 from its extracellular domain, leading to enhancement of CSC‐like properties and EMT. This signalling was associated with enhanced chemoresistance against gemcitabine and cisplatin. Inhibition of Tspan15 or ADAM10 is a promising therapeutic strategy in ICC, as Tspan15 or ADAM10 knockdown or treatment with ADAM10 inhibitor reduced chemoresistance and invasiveness by suppressing Notch1‐mediated CSC‐like properties and EMT.
Conclusions
Tspan15‐ADAM10‐Notch1 signalling is associated with aggressive tumour progression and poor prognosis in ICC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of General Surgery, Graduate School of Medicine, Chiba University, Chiba, Japan.
ORCID-Profile: Satoshi Kuboki
Förderung
- Japan Society for the Promotion of Science
Zitieren
APA
Yoshizumi, A., Kuboki, S., Takayashiki, T., Takano, S., Takayanagi, R., Sonoda, I., & Ohtsuka, M. (2023). Tspan15‐ADAM10 signalling enhances cancer stem cell‐like properties and induces chemoresistance via Notch1 activation in ICC. Liver International. https://doi.org/10.1111/liv.15691
Vancouver
Yoshizumi A, Kuboki S, Takayashiki T, Takano S, Takayanagi R, Sonoda I, et al. Tspan15‐ADAM10 signalling enhances cancer stem cell‐like properties and induces chemoresistance via Notch1 activation in ICC. Liver International. 2023. doi:10.1111/liv.15691
BibTeX
@article{Yoshizumi2023,
author = {Yoshizumi, Arihito and Kuboki, Satoshi and Takayashiki, Tsukasa and Takano, Shigetsugu and Takayanagi, Ryosuke and Sonoda, Itaru and Ohtsuka, Masayuki},
title = {Tspan15‐ADAM10 signalling enhances cancer stem cell‐like properties and induces chemoresistance via Notch1 activation in ICC},
journal = {Liver International},
year = {2023},
doi = {10.1111/liv.15691}
}
EUVIMED